Company Filing History:
3 out of 1,311 
1 out of 1 
1 out of 832,966 Years Active: 2006-2011
Title: Xianlin Han: Innovator in Neurological Disorder Detection
Introduction
Xianlin Han is a prominent inventor based in Clayton, MO (US), known for his significant contributions to the field of neurological disorder detection. With a total of 5 patents, Han has developed innovative methods and compositions that enhance the early detection and monitoring of neurodegenerative diseases.
Latest Patents
One of Han's latest patents is titled "Lipid profile as a biomarker for early detection of neurological disorders." This invention focuses on compositions and methods for the early detection or monitoring of neurodegenerative diseases, including Alzheimer's disease. It provides biomarkers based on lipid profiles of biological samples, offering a novel approach to detecting these disorders.
Another notable patent is "Multiplexing matrix-analyte stereo electronic interactions for high throughput shotgun metabolomics." This invention presents a shotgun metabolomics approach utilizing MALDI-tandem mass spectrometry for rapid analysis of cellular metabolites. By employing neutral organic solvents to inactivate endogenous enzyme activities, Han's method allows for the direct ionization and quantitation of metabolites from biological extracts without prior chromatographic separation.
Career Highlights
Throughout his career, Xianlin Han has worked with esteemed institutions, including Washington University. His innovative research has led to advancements in the understanding and detection of neurological disorders, making a significant impact in the field.
Collaborations
Han has collaborated with notable colleagues, including Richard W Gross and Gang Sun, contributing to the advancement of research in his area of expertise.
Conclusion
Xianlin Han's work in developing innovative methods for the early detection of neurological disorders showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against neurodegenerative diseases, and his patents reflect a commitment to improving healthcare outcomes.